Guse Kyle 4
4 · ATOSSA THERAPEUTICS, INC. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Guse Kyle
CFO & General Counsel
Transactions
- Award
Stock Option (right to buy)
2022-02-24+746,667→ 746,667 totalExercise: $1.25Exp: 2032-02-24→ Common Stock (746,667 underlying)
Footnotes (1)
- [F1]The options will vest on a quarterly basis over two (2) years.